TUSC8 and breast cancer: Additionally, for the expression levels of TUSC8 in different stages of breast cancer patients in TCGA cohort, the results suggested that TUSC8 expression reduced gradually from stage I to stage IV (p < 0.05, p < 0.01 respectively) (Figure 1D), indicating that TUSC8 was associated with breast cancer progression.